
zzso cells induce excessive zzso zzso zzso bone zzso and subsequent release of growth factors and calcium from bone zzso resulting in a zzso zzso of bone breakdown and tumor zzso zzso zzso zzso is an essential zzso of zzso formation, function, and zzso In zzso prostate cancer models, zzso zzso directly prevents zzso via blockade of zzso and indirectly reduces progression of skeletal tumor burden by reducing local growth factor and calcium zzso zzso a well-established chemotherapy for zzso zzso prostate cancer, arrests the cell cycle and zzso zzso of tumor zzso zzso of zzso through zzso zzso may enhance the effects of zzso on skeletal zzso We evaluated the combination of the zzso inhibitor zzso zzso with zzso in a zzso model of prostate cancer bone zzso zzso zzso tumor area, and tumor proliferation and zzso were zzso zzso alone reduced bone zzso zzso zzso zzso versus zzso inhibited progression of established zzso zzso and reduced tumor area zzso zzso zzso versus zzso zzso alone reduced tumor burden zzso zzso zzso versus zzso and delayed the development of zzso zzso zzso in combination with zzso suppressed skeletal tumor burden zzso zzso zzso and increased median survival time by zzso zzso zzso zzso compared with zzso zzso zzso zzso may enhance zzso effects by increasing tumor cell zzso as evident by increased active zzso These studies show that zzso of zzso provides an additive benefit to zzso treatment in a zzso model of prostate cancer bone zzso and supports clinical evaluation of this treatment option in zzso 

